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Abstract
Parts of the plant Thalictrum rhyncocarpum are used in herbal medicine in Kenya to treat various infections. The
aim of this study was to evaluate in-vitro anti-bacteria activities and phytochemical profiles of solvent extracts of the leaves,
stem bark and root of Thalictrum rhyncocarpum against Bacillus subtilis-6633, Staphylococcus aures-SG 511, Escherichia
coli SG 458, Pseudomonus aeruginosa-K799/61 and Mycobacterium vaccae-10670. Anti-bacterial activity tests were carried
out using disc diffusion assay and tube dilution technique, and phytochemical screening was carried out through Thin Layer
Chromatography. The crude extracts showed antibacterial effects on M. vaccae, P. aeruginosa and B. subtilis. M. vaccae was
most sensitive, particularly to the methanol root extract. Phytochemical screening of the extracts suggested the presence of
glycosides and alkaloids in the stem bark and root extracts, and flavonoids and triterpenes in the leaf extracts. The study
showed interesting levels of activities of solvent extracts of different parts of T. rhyncocarpum against some of the bacteria
tested (M. vaccae, P. aeruginosa and B. subtilis). The results provide some scientific rationale for the traditional use of the
plant in Kenya to treat different microbial infections.
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Introduction
The use of plants in traditional medicine has been well documented in many parts of the world (UNESCO, 1997-
1998 and Otieno et al., 2008). According to the World Health Organisation (WHO, 2008), 65% of the world’s population
have incorporated ethnomedicine in their primary health care practice. In some African and Asian countries, 80% of the
population depends on traditional medicine for primary health care and about 70% of population in the developed world has
used alternative or complementary medicines (WHO, 2008). In India, traditional healers use about 2500 plant species as a
regular source of medicine to treat different diseases (Mathu et al., 2006). However, only a small proportion of medicinal
plants (10%) has been studied scientifically (Lai & Roy, 2004; Tapsell et al., 2006). For example, of the plants used to treat
microbial infections, an estimated 6% have been screened for specific anti-microbial activities and only a small proportion of
these have been studied phytochemically to identify the active constituents and/or blends (Fabrican and Farnsworth, 2001;
Tapsell et al., 2006).
The genus Thalictrum comprises 120 species of perennial herbaceous plants. In India, species of the genus have
been used as tonic, aperient, diuretic, antiseptic and for the treatment of stomach discomfort, snake bites, jaundice,
rheumatism and microbial infections (Zerrin et al., 2004). In China, 43 species of this genus are used to treat lung cancer,
cough and dysentry (Bao et al., 2003). In West Africa, the plant T. rhyncocarpam is used to accelerate wound healing and
cure breast cancer (Boily & Puyvelde, 2002). In South Africa, water extracts of leaf, stem bark and roots of T. simplex are
used to cure viral influenza. In the Democratic Republic of Congo, crude extracts of T. rhyncocarpum are used to control
Bacillus subtilis, Candida albicans, Mycobacterium smegmatis, Pseudomonas aeruginosa, Salmonella gallinarum and
Staphylococcus aureus (Boily & Puyvelde, 2002).
A number of species in this genus have been screened for in vitro anti-bacterial activities against both Gram-
positive and Gram-negative bacteria associated with human diseases (Ferzaneh et al., 2008). For example, methanol extract
of aerial parts of T. minus demonstrated high in-vitro activity against Salmonela typhi (Ferzaneh et al., 2008). Water extracts
of T. orientale exhibited anti-microbial activity against Staphylococcus aureus, Salmonella gallinarum, Pseudomonas
aeruginosa, Klebsiella pneumonia and Candida albicans at a concentration of 1000 μl/ml (Erdemgil et al., 2004). T. simplex
methanol and water extracts were found to exhibit in-vitro activity against the influenza virus (Julia & Maria, 2003).
Phytochemical studies of the species studied to date have led to the isolation of a large number bioactive alkaloids
and some sesquiterpenoids. Almost all the alkaloids belong to the isoquinoline group. Their biological activities include
hypotensive, antimicrobial and antitumour properties (Adnan et al., 1999). A novel oxobenzylisoquinoline alkaloid,
thalprzewalskiinone, isolated from the roots of T. przewalskii, demonstrated in-vitro activity against both Gram-positive and
Gram-negative bacteria (Adnan et al., 1999). Thalicoside A1, A2, and A3 (structural derivatives of thalpuzewalskiinone)
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have been isolated from aerial parts of T. minus with thalicoside A2 exhibiting in-vitro inhibition of the fungus Candida
albicans and antibacterial activity against Staphylococcus aureus (Alexandra et al., 2000). A glycosyl triterpenoid, 3-O-β-D-
glucopyranosyl-(1,4)-β-D-fucopyranosyl (22S, 24Z)-cycloart-24-ene-3β, 22, 26-trio 26-O-β-D-glucopyranoside, isolated
from T. fortunei, demonstrated anti-tumour activity against NCIH-460 and sac-7901 cancer cells (Xiantao et al., 2011).
In Kenya, T. rhycocarpum has been used extensively in traditional medicine to treat stomach ulcers, snake bites,
dysentery and skin rashes (Jeruto et al., 2011). This study reports on in-vitro anti-microbial activities of organic extracts of
leaves, stem bark and root extracts of T. rynchocarpum and their phytochemical profiles.
Materials and Methods
Plant materials
The leaves, roots and stem barks of Thalictrum rhyncocarpum were collected in November 2010 in Ngong forest in
Nairobi county, Kenya (37 °08 E and 0 ° 13 S). The plant species was authenticated at the University of Nairobi Herbarium,
where a specimen is preserved (Voucher number TR-NG-203).
Plant materials preparation
The collected plant materials were transported to Kenyatta University. The leaves, stem barks, and roots were
separated, and these were allowed to dry under shade for a period of 14 days. The air dried plant materials were separately
ground into powder using an electric grinder. The powdered materials were then stored at room temperature (21-26 oC) until
extracted.
Extraction
Extraction of the plant materials was carried out for three successive days. Ground leaves were extracted with
different analytical grade solvents (Fluka) to target different groups of constituents: leaf powder with dichloromethane, stem
bark powder using 1:1 mixture of dichloromethane and methanol, and powdered root with methanol (Xiantao et al., 2011).
The solvents extracts were filtered separately and concentrated in vacuo.
Disc diffusion assay for anti-bacterial activity
The disc diffusion method (Jorgensen et al., 1999; Joseph et al., 2006) was used to screen for antibacterial activities
of the crude extracts against the five bacterial strains. Approximately 9 mL of Müller-Hinton agar (Oxoid, UK) was poured
into petri dishes (9 cm in diameter) and inoculated with the respective test organisms. Wells (4 mm) were punched out of the
solid agar using pipette tips, and 1 ml of 50 μg/mL of the test extracts or control antibiotic Ciprofloxacin (5 μg/ml) placed in 
different wells. The petri dishes were incubated at 30 oC for 20 h and the average diameter of the inhibition zones
surrounding the wells computed from three sets of replicates.
Tube dilution assay test
The minimum inhibitory concentrations (MIC) of the extracts were determined using a serial micro-plate dilution
assay (Ravi et al., 2010) against each test bacterial species. This was determined by 2-fold serial dilution of the extracts
beyond the level where no inhibition of growth of the bacterial strains was observed. Each extract was reconstituted to 100
μg/ml in DMSO and 100 μl aliquot which was serially diluted with equal amounts of water in 96-well microplates. The test 
bacteria were inoculated into Muller-Hinton (MH) broth culture (1%), incubated at 37oC overnight, and 100 µl aliquots of the
resulting culture added to each well. Ciprofloxacin at a concentration of 100 μg/ml was used as a positive control and 
untreated wells used as negative controls. The microplates were sealed and incubated at 37 oC and 100% relative humidity for
18 h. As an indicator of bacterial growth, 40 μL aliquots of a 0.2 mg/mL solution of p-iodonitrotetrazolium violet (INT)
dissolved in water was added to the microplate wells and incubated at 37 oC for 30 min. The MIC value was recorded as the
lowest concentration of the extract at which bacterial growth was inhibited.
Phytochemical screening
The crude extracts of T. rhynchocarpum were screened for the presence of terpenes, flavonoids, glycosides and
alkaloids using standard qualitative procedures (Jorge et al., 2011). P-Anisaldehyde and Dragendorff solutions were used as
thin layer chromatography spray reagents.
Results and discussion
Anti-microbial activities of the crude extracts
Table 1 summarises the results of disc diffusion assays of the crude solvent extracts of T. rhyncocarpum. All the
three extracts showed high activities against M. vaccae, moderate activities against B. subtilis and P. aeruginosa, but no
significant activity against S. aures and E. coli. The inhibitory activity of methanol root extract against M. vaccae was 6.9 ±
1.7 μg/ml which was significantly higher (P < 0.05) than that of the standard synthetic anti-bacteria agent ciprofloxacin 
Wafula et al., Afr J Tradit Complement Altern Med. (2013) 10(5):341-344
http://dx.doi.org/10.4314/ajtcam.v10i5.20
343
which activity was 10.3 ± 1.3 μg/ml. The activity of the leaf extracts against M. Vaccae was 17.2 ± 1.2 μg/ml while that of 
stem bark extracts was 15.1 ± 1.4 μg/ml, both of which were significantly lower than that of ciprofloxacin.  
Table 1: Anti-bacteria activities (as reflected in MIC values) of T. rhyncocarpum extracts
Extract code B. subtilis (μg/ml) S. aures (μg/ml) E. coli (μg/ml) 
P. aeruginosa
(μg/ml) M. vaccae (μg/ml) 
1 31.2a ± 2.1 >100a >100a 28.4b ± 2.3 17.2a ± 1.2
2 24.4b ± 1.3 >100a >100a 42.1a ± 2.0 15.1b ± 1.4
3 21.5c ± 2.4 >100a >100a 23.6c ±2.2 6.9d ± 1.7
Ciprofloxacin 9.6d ± 1.1 11.3b ± 1.4 8.4b ± 1.9 12.4d ± 3.2 10.3c ± 1.3
1: Leaf extract; 2: stem bark extract; 3: root extract. Means with different letters in a column are significantly different (SNK,
p <. 0.05)
Phytochemical screening of crude extracts
Table 2 summarises results of phytochemical screening of the two extracts. Phytochemical screening of the three
extracts suggested the presence of triterpenes, flavonoids and glycosides in leaf, stem bark and root extracts. Since triterpenes
and glycosides give similar responses to anisaldehyde, the extracts may contain either of the two classes of compounds or
both. The presence of alkaloids was suggested in stem bark and root extracts. Previously, it was reported that the genus
Thalictrum is rich mainly in benzylisoquinoline alkaloids (Zhu & Xiao, 1991). However, recent reports indicate that the
genus is also characterised by several classes of compounds originating from different biosynthetic pathways, including
cycloartene-type triterpenes, triterpenoid glycosides (Hitoshi et al., 2000; Ziantao et al., 2011). The genus may also be a
unique source of structurally important fatty acids with a trans-double bond at C5 (Jinn & Amitabha, 1980). Bio-activity-
guided fractionation, isolation and characterisation of the active constituents and blends of T. rhyncocarpum extracts are
underway.
Table 2: Phytochemical screening of crude extracts using p-anisaldehyde
Test Reagent
Extract Anisaldehyde Dragendorf
1 + (Triterpene/flavonoids/glycosides) - (No alkaloids)
2 + (Flavonoids) + (Alkaloids)
3 + (Triterpenes/glycosides) + (Alkaloids)
1: Leaf extract; 2: stem bark extract; 3: root extract
Conclusions
The present study shows interesting levels of activities of solvent extracts of different parts of T. rhyncocarpum
against some of the bacteria tested (M. vaccae, P. aeruginosa and B. subtilis). The results provide some scientific rationale
for the traditional use of the plant in Kenya to treat different microbial infections. Initial screening of the extracts suggests the
presence of secondary metabolites derived from different biosynthetic pathways. Bioassay-guided fractionation, isolation and
characterisation of the constituents are expected to identify the compounds and/or blends responsible for the observed
activities.
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